Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iron overload states.

B R Bacon1

  • 1Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, Missouri 63110-0250, USA.

Clinics in Liver Disease
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Hereditary hemochromatosis, a common iron metabolism disorder, is now diagnosed earlier. Discovering its candidate gene improves understanding of iron absorption and metabolism, benefiting other liver diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.

Journal of viral hepatitis·2016
Same author

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.

Journal of viral hepatitis·2016
Same author

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.

Alimentary pharmacology & therapeutics·2013
Same author

Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy.

Alimentary pharmacology & therapeutics·2010
Same author

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.

Alimentary pharmacology & therapeutics·2008
Same author

Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.

American journal of physiology. Gastrointestinal and liver physiology·2006
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Area of Science:

  • Genetics
  • Hepatology
  • Metabolic Disorders

Background:

  • Hereditary hemochromatosis is a prevalent iron metabolism disorder.
  • Early diagnosis and treatment are becoming more common, preventing complications like cirrhosis and diabetes.

Purpose of the Study:

  • To highlight the significance of the hereditary hemochromatosis candidate gene discovery.
  • To emphasize the gene's role in advancing the understanding of iron metabolism.

Main Methods:

  • The abstract does not specify methods, focusing on the implications of a gene discovery.

Main Results:

  • The discovery of a candidate gene for hereditary hemochromatosis is a significant breakthrough.
  • This discovery promises to enhance diagnostic capabilities for the condition.

Related Experiment Videos

Conclusions:

  • Improved diagnosis and understanding of hereditary hemochromatosis are expected.
  • Insights into iron biology gained from this discovery can be applied to other hepatic diseases, including chronic viral hepatitis.